KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Virginia

HB1347 • 2026

Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.

An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes.

Healthcare
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Cohen
Last action
2026-04-06
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

The official source does not specify the exact timeline or procedures for rescheduling beyond FDA approval and federal publication.

Psilocybin Rescheduling Act

This act requires the Board of Pharmacy to change how psilocybin is regulated based on federal scheduling changes after FDA approval.

What This Bill Does

  • Requires the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon FDA approval of a formulation designed for medical use by health care professionals.

Who It Names or Affects

  • Board of Pharmacy
  • Health care professionals who might administer psilocybin

Terms To Know

Psilocybin
A chemical found in certain mushrooms that can affect the brain and cause hallucinations.
FDA
The U.S. Food and Drug Administration, a government agency that regulates food, drugs, and medical devices.

Limits and Unknowns

  • Does not specify what happens if the FDA does not approve psilocybin for medical use.
  • It is unclear how quickly the Board of Pharmacy will act after federal changes are published.

Bill History

  1. 2026-04-06 Governor

    Approved by Governor-Chapter 305 (effective 7/1/2026)

  2. 2026-04-06 Governor

    Approved by Governor-Chapter 305 (effective 7/1/2026)

  3. 2026-04-06 Governor

    Acts of Assembly Chapter text (CHAP0305)

  4. 2026-03-10 House

    Enrolled Bill communicated to Governor on March 10, 2026

  5. 2026-03-10 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  6. 2026-03-02 House

    Signed by Speaker

  7. 2026-03-02 Senate

    Signed by President

  8. 2026-03-02 House

    Enrolled

  9. 2026-03-02 House

    Bill text as passed House and Senate (HB1347ER)

  10. 2026-03-02 House

    Fiscal Impact Statement from Department of Planning and Budget (HB1347)

  11. 2026-02-25 House

    Senate substitute agreed to by House (96-Y 0-N 0-A)

  12. 2026-02-23 Senate

    Read third time

  13. 2026-02-23 Senate

    Engrossed by Senate - committee substitute

  14. 2026-02-23 Senate

    Passed Senate with substitute Block Vote (38-Y 0-N 0-A)

  15. 2026-02-23 Education and Health

    Education and Health Substitute agreed to

  16. 2026-02-23 Senate

    Passed Senate with substitute Block Vote (38-Y 0-N 0-A)

  17. 2026-02-20 Senate

    Rules suspended

  18. 2026-02-20 Senate

    Rules suspended

  19. 2026-02-20 Senate

    Passed by for the day

  20. 2026-02-20 Senate

    Constitutional reading dispensed Block Vote (on 2nd reading) (40-Y 0-N 0-A)

  21. 2026-02-20 Senate

    Passed by for the day Block Vote (Voice Vote)

  22. 2026-02-20 Education and Health

    Committee substitute printed 26108278D-S1

  23. 2026-02-20 Education and Health

    Fiscal Impact Statement from Department of Planning and Budget (HB1347)

  24. 2026-02-19 Education and Health

    Reported from Education and Health with substitute (15-Y 0-N)

  25. 2026-02-19 Senate

    Senate committee offered

  26. 2026-02-12 Senate

    Constitutional reading dispensed (on 1st reading)

  27. 2026-02-12 Education and Health

    Referred to Committee on Education and Health

  28. 2026-02-11 House

    Read third time and passed House Block Vote (96-Y 0-N 0-A)

  29. 2026-02-11 House

    Reconsideration of passage agreed to by House

  30. 2026-02-11 House

    Passed House Block Vote (98-Y 0-N 0-A)

  31. 2026-02-10 House

    Read second time and engrossed

  32. 2026-02-09 House

    Read first time

  33. 2026-02-09 House

    Fiscal Impact Statement from Department of Planning and Budget (HB1347)

  34. 2026-02-05 Health and Human Services

    Reported from Health and Human Services (22-Y 0-N)

  35. 2026-02-03 Health

    Subcommittee recommends reporting (9-Y 1-N)

  36. 2026-01-23 Health

    Assigned sub: Health

  37. 2026-01-19 House

    Presented and ordered printed 26105580D

  38. 2026-01-19 Health and Human Services

    Referred to Committee on Health and Human Services

Official Summary Text

Board of Pharmacy; regulation of psilocybin.
Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to SB 379.

Current Bill Text

Read the full stored bill text 
An Act to direct the Board of Pharmacy to reschedule psilocybin upon federal scheduling changes.
Be it enacted by the General Assembly of Virginia:
1.
§ 1. Upon approval by the U.S. Food and Drug Administration (FDA) of a formulation of psilocybin designed to be administered by a health care professional in a health care setting, the Board of Pharmacy shall reschedule such formulation of psilocybin consistent with federal scheduling changes and procedures contained in subsection E of §
54.1-3443
of the Code of Virginia at its next quarterly meeting following the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule designating any formulation of psilocybin that has been approved by the FDA as a controlled substance.